Cutting-edge multi-level analytical and structural characterization of antibody-drug conjugates: present and future
Published inExpert Review of Proteomics, vol. 16, no. 4, p. 337-362
Publication date2019
Abstract
Keywords
- Brentuximab vedotin
- Trastuzumab emtansine
- Gemtuzumab ozogamicin
- Inotuzumab ozogamicin
- Sacituzumab govitecan
- 3G-ADCs
- Small-protein
- Fragment-DCs
Affiliation
Research group
Funding
- Swiss National Science Foundation - 31003A 159494
Citation (ISO format)
BECK, Alain et al. Cutting-edge multi-level analytical and structural characterization of antibody-drug conjugates: present and future. In: Expert Review of Proteomics, 2019, vol. 16, n° 4, p. 337–362. doi: 10.1080/14789450.2019.1578215
Main files (1)
Article (Published version)
![accessLevelRestricted](assets/images/access-level-restricted.png)
Identifiers
- PID : unige:121499
- DOI : 10.1080/14789450.2019.1578215
- PMID : 30706723
ISSN of the journal1478-9450